2020年6月11日 · The Canadian Network for Mood and Anxiety Treatments (CANMAT) is a network of academic and clinical experts dedicated to improving clinical care for people with mood and anxiety disorders. We provide up-to-date scientific information, treatment guidelines and educational activities for health professionals, and clear and useful information ...

The 2018 Bipolar Guidelines by CANMAT provide evidence-based recommendations for the diagnosis and treatment of bipolar disorder.

CANMAT's evidence-based clinical guidelines for the diagnosis and treatment of adults with Major Depressive Disorder (MDD), designed for use by community-based psychiatrists and mental health professionals.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously pub-lished treatment guidelines for bipolar disorder in 2005, along with international com-mentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar Disorders (ISBD).

CANMAT's 2016 Depression Guidelines provide evidence-based recommendations for the diagnosis and treatment of depression.

2019年3月27日 · Evidence-based clinical guidelines developed by CANMAT and the ­International Society for Bipolar Disorder (ISBD) for the diagnosis and treatment of Bipolar Disorders, designed for use by community-based psychiatrists and mental health professionals.

The new Patient and Family Guide to the CANMAT and ISBD Guidelines on Bipolar Disorder, released in March 2020.

for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. youth, women, and the elderly.

2019年9月12日 · A guide for patients and families to understand the different evidence-based treatments available for bipolar disorder as per the CANMAT and ISBD 2018 Guidelines on the Management of Bipolar Disorder.

2020年3月19日 · The Patient and Family Guide translates the key principles of the CANMAT and ISBD clinical guidelines for bipolar disorder so that they are accessible to non-clinicians, including patients their families.